Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Pancreatic-carcinoma-cell-derived pro-angiogenic factors can induce endothelial-cell differentiation of a subset of circulating CD34+ progenitors.

Vizio B, Biasi F, Scirelli T, Novarino A, Prati A, Ciuffreda L, Montrucchio G, Poli G, Bellone G.

J Transl Med. 2013 Dec 17;11:314. doi: 10.1186/1479-5876-11-314.

2.
3.

Fibronectin promotes VEGF-induced CD34 cell differentiation into endothelial cells.

Wijelath ES, Rahman S, Murray J, Patel Y, Savidge G, Sobel M.

J Vasc Surg. 2004 Mar;39(3):655-60.

4.

Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions.

Schmeisser A, Garlichs CD, Zhang H, Eskafi S, Graffy C, Ludwig J, Strasser RH, Daniel WG.

Cardiovasc Res. 2001 Feb 16;49(3):671-80.

5.
6.

High levels of circulating VEGFR2+ Bone marrow-derived progenitor cells correlate with metastatic disease in patients with pediatric solid malignancies.

Taylor M, Rössler J, Geoerger B, Laplanche A, Hartmann O, Vassal G, Farace F.

Clin Cancer Res. 2009 Jul 15;15(14):4561-71. doi: 10.1158/1078-0432.CCR-08-2363.

7.

Stem cell-like human endothelial progenitors show enhanced colony-forming capacity after brief sevoflurane exposure: preconditioning of angiogenic cells by volatile anesthetics.

Lucchinetti E, Zeisberger SM, Baruscotti I, Wacker J, Feng J, Zaugg K, Dubey R, Zisch AH, Zaugg M.

Anesth Analg. 2009 Oct;109(4):1117-26. doi: 10.1213/ANE.0b013e3181b5a277.

PMID:
19762739
8.

Efficient commitment to functional CD34+ progenitor cells from human bone marrow mesenchymal stem-cell-derived induced pluripotent stem cells.

Xu Y, Liu L, Zhang L, Fu S, Hu Y, Wang Y, Fu H, Wu K, Xiao H, Liu S, Yu X, Zheng W, Feng B, Huang H.

PLoS One. 2012;7(4):e34321. doi: 10.1371/journal.pone.0034321. Epub 2012 Apr 9. Erratum in: PLoS One. 2012;7(8). doi:10.1371/annotation/ebddb7ce-712c-4f9d-8412-20dc827c30b9.

9.

Human CD34/CD90 ASCs are capable of growing as sphere clusters, producing high levels of VEGF and forming capillaries.

De Francesco F, Tirino V, Desiderio V, Ferraro G, D'Andrea F, Giuliano M, Libondi G, Pirozzi G, De Rosa A, Papaccio G.

PLoS One. 2009 Aug 6;4(8):e6537. doi: 10.1371/journal.pone.0006537.

10.

Junctional adhesion molecule A expressed on human CD34+ cells promotes adhesion on vascular wall and differentiation into endothelial progenitor cells.

Stellos K, Langer H, Gnerlich S, Panagiota V, Paul A, Schönberger T, Ninci E, Menzel D, Mueller I, Bigalke B, Geisler T, Bültmann A, Lindemann S, Gawaz M.

Arterioscler Thromb Vasc Biol. 2010 Jun;30(6):1127-36. doi: 10.1161/ATVBAHA.110.204370. Epub 2010 Apr 8.

11.

Immunological and ultrastructural characterization of endothelial cell cultures differentiated from human cord blood derived endothelial progenitor cells.

Neumüller J, Neumüller-Guber SE, Lipovac M, Mosgoeller W, Vetterlein M, Pavelka M, Huber J.

Histochem Cell Biol. 2006 Dec;126(6):649-64. Epub 2006 Jun 10.

PMID:
16767408
12.

Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer.

Dome B, Timar J, Dobos J, Meszaros L, Raso E, Paku S, Kenessey I, Ostoros G, Magyar M, Ladanyi A, Bogos K, Tovari J.

Cancer Res. 2006 Jul 15;66(14):7341-7.

13.

Endothelial progenitor cells derived from CD34+ cells form cooperative vascular networks.

Guo S, Cheng Y, Ma Y, Yang X.

Cell Physiol Biochem. 2010;26(4-5):679-88. doi: 10.1159/000322335. Epub 2010 Oct 29.

PMID:
21063105
14.

A comparison of CFU-GM, BFU-E and endothelial progenitor cells using ex vivo expansion of selected cord blood CD133(+) and CD34(+) cells.

Lu X, Baudouin SV, Gillespie JI, Anderson JJ, Dickinson AM.

Cytotherapy. 2007;9(3):292-300.

PMID:
17464761
15.

Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell function.

Hill KL, Obrtlikova P, Alvarez DF, King JA, Keirstead SA, Allred JR, Kaufman DS.

Exp Hematol. 2010 Mar;38(3):246-257.e1. doi: 10.1016/j.exphem.2010.01.001. Epub 2010 Jan 11.

16.
17.

Presence of endothelial progenitor cells, distinct from mature endothelial cells, within human CD146+ blood cells.

Delorme B, Basire A, Gentile C, Sabatier F, Monsonis F, Desouches C, Blot-Chabaud M, Uzan G, Sampol J, Dignat-George F.

Thromb Haemost. 2005 Dec;94(6):1270-9.

PMID:
16411405
18.

Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction.

Wojakowski W, Tendera M, Michałowska A, Majka M, Kucia M, Maślankiewicz K, Wyderka R, Ochała A, Ratajczak MZ.

Circulation. 2004 Nov 16;110(20):3213-20. Epub 2004 Nov 8.

19.

Pilot study to relate clinical outcome in pancreatic carcinoma and angiogenic plasma factors/circulating mature/progenitor endothelial cells: Preliminary results.

Vizio B, Novarino A, Giacobino A, Cristiano C, Prati A, Brondino G, Ciuffreda L, Bellone G.

Cancer Sci. 2010 Nov;101(11):2448-54. doi: 10.1111/j.1349-7006.2010.01692.x.

20.

Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients.

Igreja C, Courinha M, Cachaço AS, Pereira T, Cabeçadas J, da Silva MG, Dias S.

Haematologica. 2007 Apr;92(4):469-77.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk